Mortality rates from breast cancer
Dear OncoLink "Ask The Experts,"
Kevin Fox, MD Assistant Director, Clinical Affairs and Associate Professor of Hematology/Oncology at the Abramson Cancer Center of the University of Pennsylvania responds:
It can be frustrating to the individual observer when looking at overall mortality figures. Overall mortality from breast cancer has dropped, but only by a little bit. The two most likely reasons are early detection from increased use of mammography, and from more effective drug therapies (adjuvant therapies) for patients with early stages of disease. By catching breast cancer at an earlier stage, we should be able to impact survival over time, but this may take many years to prove. Similarly, with the addition of new adjuvant therapies and broader distribution and availability, we hope to see this trend continue.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2016 Trustees of The University of Pennsylvania